Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

HQ-HTN-G01 is a prospective, multicenter, single arm, open label, early feasibility study to evaluate initial safety and device design concept of "HyperQureTM RDN System", laparoscopic renal denervation therapy, in patients with resistant hypertension on three(3) or more antihypertensive medications

Participants needed: 15
Trial details
Age: 22-80Biological sex: AllType: InterventionalSponsor: DeepQure Inc.Updated: Dec 4, 2025Locations: 5
Eligibility criteria

Aged ≥22 and ≤80 years old at time of enrollment (consent). [+4]

Has coverage diameter of renal artery less than 2 mm or greater than 11 mm. [+42]

Status: Recruiting

A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension

HQ-HTN-K01-02 is a prospective, multicenter, single arm, open label, first-in-human study to evaluate the safety and initial efficacy of HyperQureTM, laparoscopic denervation therapy, in patients with resistant hypertension on 3 or more antihypertensive medications

Participants needed: 10
Trial details
Age: 19-79Biological sex: AllType: InterventionalSponsor: DeepQure Inc.Updated: Dec 4, 2025Locations: 7
Eligibility criteria

Male and female patients aged between 19 and 79 years old [+8]

Those with the following confirmed anatomical findings in the kidney or renal ar... [+51]